KR830009023A - 피롤리딘 유도체의 제조방법 - Google Patents

피롤리딘 유도체의 제조방법 Download PDF

Info

Publication number
KR830009023A
KR830009023A KR1019820000475A KR820000475A KR830009023A KR 830009023 A KR830009023 A KR 830009023A KR 1019820000475 A KR1019820000475 A KR 1019820000475A KR 820000475 A KR820000475 A KR 820000475A KR 830009023 A KR830009023 A KR 830009023A
Authority
KR
South Korea
Prior art keywords
hydroxy
pyrrolidine derivative
methoxybenzoyl
preparing pyrrolidine
preparing
Prior art date
Application number
KR1019820000475A
Other languages
English (en)
Inventor
아쉬반 덴 베르너
키부르츠 에밀리오
Original Assignee
쿠르트 네셀보쉬, 한스 스튀클린
에프ㆍ호프만-라롯슈 앤드 캄파니 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쿠르트 네셀보쉬, 한스 스튀클린, 에프ㆍ호프만-라롯슈 앤드 캄파니 아크티엔 게젤샤프트 filed Critical 쿠르트 네셀보쉬, 한스 스튀클린
Publication of KR830009023A publication Critical patent/KR830009023A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

내용 없음

Description

피롤리딘 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 다음 일반식(II)의 피롤리딘 유도체로부터 보호그룹을 제거함을 특징으로 하여 다음 일반식(I)의 1-(3-하이드록시-4-메톡시벤조일)-3-하이드록시-2-피롤리디논을 제조하는 방법.
    상기 일반식에서,
    R1및 R2중 하나는 보호그룹이고 다른 하나는 수소 또는 보호그룹이다.
  2. 제1항에 있어서, (R,S)-1-(3-하이드록시-4-메톡시벤조일)-3-하이드록시-2-피롤리디논을 제조하는 방법.
  3. 제1항에 있어서, (R)-1-(3-하이드록시-4-메톡시벤조일)-3-하이드록시-2-피롤리디논을 제조하는 방법.
  4. 제1항에 있어서, (S)-1-(3-하이드록시-4-메톡시벤조일)-3-하이드록시-2-피롤리디논을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019820000475A 1981-02-05 1982-02-04 피롤리딘 유도체의 제조방법 KR830009023A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH770/81 1981-02-05
CH77081A CH646149A5 (de) 1981-02-05 1981-02-05 Pyrrolidin-derivat.

Publications (1)

Publication Number Publication Date
KR830009023A true KR830009023A (ko) 1983-12-17

Family

ID=4194769

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019820000475A KR830009023A (ko) 1981-02-05 1982-02-04 피롤리딘 유도체의 제조방법

Country Status (40)

Country Link
US (1) US4452807A (ko)
EP (1) EP0057846B1 (ko)
JP (1) JPS57146753A (ko)
KR (1) KR830009023A (ko)
AR (1) AR231127A1 (ko)
AT (2) ATE13668T1 (ko)
AU (1) AU552063B2 (ko)
BG (1) BG36932A3 (ko)
BR (1) BR8200615A (ko)
CA (1) CA1158250A (ko)
CH (1) CH646149A5 (ko)
CS (1) CS227035B2 (ko)
DD (1) DD202539A5 (ko)
DE (2) DE3202281A1 (ko)
DK (1) DK20682A (ko)
ES (1) ES8304545A1 (ko)
FI (1) FI820192L (ko)
FR (1) FR2499075A1 (ko)
GB (1) GB2092584B (ko)
GR (1) GR76052B (ko)
HU (1) HU184988B (ko)
IE (1) IE52439B1 (ko)
IL (1) IL64896A (ko)
IS (1) IS2700A7 (ko)
IT (1) IT1153402B (ko)
LU (1) LU83923A1 (ko)
MC (1) MC1440A1 (ko)
NL (1) NL8200337A (ko)
NO (1) NO820346L (ko)
NZ (1) NZ199624A (ko)
OA (1) OA07002A (ko)
PH (1) PH18267A (ko)
PL (1) PL135221B1 (ko)
PT (1) PT74387B (ko)
RO (1) RO83099B (ko)
SE (1) SE8200647L (ko)
SU (1) SU1143315A3 (ko)
YU (1) YU23982A (ko)
ZA (1) ZA82608B (ko)
ZW (1) ZW1982A1 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
FR2551751B1 (fr) * 1983-09-12 1986-04-25 Serobiologiques Lab Sa Nouveau procede de preparation d'un derive pyroglutamique, nouveaux derives pyroglutamiques, nouveaux intermediaires de synthese de preparation de ceux-ci et utilisation ou application des derives pyroglutamiques comme agents antibacteriens ou antifongiques
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3632589A1 (de) * 1985-10-18 1987-04-23 Bayer Ag Verfahren zur herstellung von (gamma)-butyrolactamen
DE3537075A1 (de) * 1985-10-18 1987-04-23 Bayer Ag Verfahren zur herstellung von clausenamid
US4677114A (en) * 1985-11-22 1987-06-30 Warner-Lambert Company Pyrrolidone-2 derivatives and pharmaceutical compositions thereof
IT1215587B (it) * 1987-06-26 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale.
JPH0720930B2 (ja) * 1988-07-09 1995-03-08 明治製菓株式会社 ピロリジノン化合物及び脳機能障害改善剤
US5049577A (en) * 1990-01-29 1991-09-17 E. R. Squibb & Sons, Inc. 2-pyrrolidone substituted dihydroxy alkanoic, alkenoic and alkynoic acids, compositions and HMG-CoA reductase inhibition therewith
US5049578A (en) * 1990-03-09 1991-09-17 E. R. Squibb & Sons, Inc. 1-aroyl or 1-acyl-2-2pyrrolidinyl-3,5-dihydroxy alkanoic and alkenoic acids, salts, esters and lactones
AU688271B2 (en) * 1992-07-24 1998-03-12 Regents Of The University Of California, The Drugs that enhance synaptic responses mediated by ampa receptors
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES433723A1 (es) * 1975-01-10 1976-11-16 Lafarquim S A Lab Procedimiento de obtencion de un derivado de 2-pirrolidi- nona.
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
NL8004025A (nl) * 1979-08-09 1981-02-11 Hoffmann La Roche Pyrrolidinederivaten en werkwijze voor het bereiden daarvan alsmede geneesmiddel.

Also Published As

Publication number Publication date
ZW1982A1 (en) 1982-09-01
IT8219115A0 (it) 1982-01-14
IE820249L (en) 1982-08-05
HU184988B (en) 1984-11-28
NL8200337A (nl) 1982-09-01
YU23982A (en) 1985-03-20
GB2092584B (en) 1984-08-01
DE3263960D1 (en) 1985-07-11
PT74387A (en) 1982-03-01
AU8010482A (en) 1982-08-12
CH646149A5 (de) 1984-11-15
DK20682A (da) 1982-08-06
GB2092584A (en) 1982-08-18
CS227035B2 (en) 1984-04-16
JPS57146753A (en) 1982-09-10
IS2700A7 (is) 1982-08-06
ES509312A0 (es) 1983-03-16
BR8200615A (pt) 1982-12-14
RO83099B (ro) 1984-02-28
PH18267A (en) 1985-05-14
ES8304545A1 (es) 1983-03-16
MC1440A1 (fr) 1982-12-06
IL64896A0 (en) 1982-03-31
SU1143315A3 (ru) 1985-02-28
ZA82608B (en) 1982-12-29
EP0057846A1 (de) 1982-08-18
PT74387B (en) 1984-10-22
IE52439B1 (en) 1987-10-28
GR76052B (ko) 1984-08-03
DE3202281A1 (de) 1982-09-16
AR231127A1 (es) 1984-09-28
ATA41882A (de) 1984-10-15
FR2499075A1 (fr) 1982-08-06
BG36932A3 (en) 1985-02-15
IT1153402B (it) 1987-01-14
AU552063B2 (en) 1986-05-22
JPH0354097B2 (ko) 1991-08-19
EP0057846B1 (de) 1985-06-05
NZ199624A (en) 1984-12-14
IL64896A (en) 1985-07-31
NO820346L (no) 1982-08-06
LU83923A1 (de) 1983-09-02
OA07002A (fr) 1983-08-31
CA1158250A (en) 1983-12-06
FI820192L (fi) 1982-08-06
PL135221B1 (en) 1985-10-31
AT377982B (de) 1985-05-28
RO83099A (ro) 1984-02-21
US4452807A (en) 1984-06-05
PL234962A1 (ko) 1982-09-27
SE8200647L (sv) 1982-08-06
DD202539A5 (de) 1983-09-21
ATE13668T1 (de) 1985-06-15

Similar Documents

Publication Publication Date Title
KR830007567A (ko) 1, 2, 3, 4-테트라하이드로이소퀴놀린-3-카복실산의 치환아실 유도체의 제조방법.
KR830000679A (ko) N-알킬화 아미노알콜의 제조방법
KR830009089A (ko) 2-펜옥시알킬-1,2,4-트리아졸-3-원 항우울제의 제조방법
KR830009023A (ko) 피롤리딘 유도체의 제조방법
KR840008317A (ko) 디할로겐화벤젠의 제조방법
KR830009084A (ko) 퀴놀린 카복실산 유도체의 제조방법
ES472747A1 (es) Procedimiento para la preparacion de derivados de aminopro- panol
KR870002090A (ko) 1-(2-옥시아미노 카보닐페닐설포닐)-3-헤테로아릴-우레아의 제조방법
KR830004292A (ko) 벤조구아나민 유도체의 제조방법
KR830003420A (ko) 피롤리딘 유도체
KR840008342A (ko) 모르포린 유도체의 제조방법
KR830010078A (ko) 이미다졸 화합물의 제조방법
KR830008990A (ko) 2-아미노-3-(할로벤조일)-메틸페닐아세트산 유도체의 제조방법
KR830005168A (ko) 5-(디하이드록시페녹시)테트라졸의 제조방법
KR870003097A (ko) (+)-6-클로로-5,10-디하이드로-5-[(1-메틸-4-피페리디닐)아세틸]-11H-디벤조 [b,e][1,4] 디아제핀-11-온의 분리방법
KR870002094A (ko) 1-(2-옥시아미노설포닐-페닐설포닐)-헤테로아릴 우레아의 제조방법
KR920009792A (ko) 3-아미노-4-메틸렌피롤리딘 유도체의 제조방법
KR890009877A (ko) 1-아실-2-피라졸린유도체의 제조방법
KR830010091A (ko) 구연산 나프티드로푸릴의 제조방법
KR860007226A (ko) 1-(하이드록시페닐)-3-메틸-4-디플루오로메틸-δ^2-1,2,4-트리아졸린-5-온 유도체의 제조방법
KR830009044A (ko) 3,5-디-3급부틸-4-하이드록시페닐-치환 복소환 화합물의 제조방법
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법
KR830004331A (ko) 스테리일 글르코사이드 유도체의 제조 방법
KR840001144A (ko) 5(6)-페닐설포닐옥시-벤즈이미다졸 유도체의 제조방법
KR830006215A (ko) 4-저급알킬-3-페녹시피리딘-1-옥사이드의 제조방법